RFI announces new delivery technologies called ProMulsion and Infusome
RFI has announced the launch of two delivery technologies, which the company will showcase at this year’s SupplySide West taking place in Las Vegas, NV on October 30-31.
Photo © AdobeStock.com/Mateusz
RFI (Orangeburg, NY) has announced the launch of two delivery technologies, which the company will showcase at this year’s SupplySide West taking place in Las Vegas, NV on October 30-31. The new technologies include Infusome and ProMulsion. ProMulsion is a line of emulsions intended for dietary supplement and nutritional product applications, even skin care that helps optimize the delivery of active ingredients, enhancing their bioavailability and efficacy.
Infusome is a new liposomal technology that ensures the optimal delivery of nutrients to cells, maximizing absorption. According to the company, each batch is subjected to rigorous particle-size testing to ensure uniformity at or below 500 nanometers.
“Nutrient delivery is one of the most important aspects of product development in the dietary supplement, nutrition, food and skin care space today and we are on the forefront with these new technologies,” said Paul Altaffer, chief innovation officer for RFI, in a press release. “Infusome and Promulsion have landed at RFI at the perfect time, as consumers become increasingly discerning about the efficacy of their health products.”
RFI will be exhibiting at SupplySide West at booth #3275.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
